Public Health Service Act
-
In Defense of Detemir: How US Drug Policy Let an Essential Insulin Disappear
•
In December 2024, Novo Nordisk discontinued insulin detemir (levemir) in the U.S. They cited manufacturing constraints, alternative insulins, and reduced formulary coverage. This decision removed one of only three basal insulin options. No generic could replace it since the FDA does not allow compounding of insulins, and expedited pathways still…